HSD17B11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.852000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.388800E-01
Normal-vs-Stage2
2.632200E-01
Normal-vs-Stage3
5.244000E-01
Normal-vs-Stage4
1.108560E-01
Stage1-vs-Stage2
6.237200E-01
Stage1-vs-Stage3
9.470800E-01
Stage1-vs-Stage4
1.638160E-01
Stage2-vs-Stage3
7.565800E-01
Stage2-vs-Stage4
1.683450E-01
Stage3-vs-Stage4
3.724000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.100600E-01
Normal-vs-AfricanAmerican
6.361900E-02
Normal-vs-Asian
5.465000E-01
Caucasian-vs-AfricanAmerican
1.447800E-01
Caucasian-vs-Asian
3.686600E-01
AfricanAmerican-vs-Asian
6.062100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.280600E-01
Normal-vs-Female
2.317400E-01
Male-vs-Female
6.972600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.514000E-01
Normal-vs-Age(41-60Yrs)
6.634100E-04
Normal-vs-Age(61-80Yrs)
3.111400E-01
Normal-vs-Age(81-100Yrs)
2.549400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.240600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.279000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.770800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.010760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.178800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.079800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.415600E-01
Normal-vs-Daily Drinker
3.850500E-02
Normal-vs-Weekly Drinker
3.458000E-01
Normal-vs-Occasional Drinker
1.831840E-01
Normal-vs-Social Drinker
3.201800E-01
Non Drinker-vs-Daily Drinker
5.503600E-01
Non Drinker-vs-Weekly Drinker
6.496600E-01
Non Drinker-vs-Occasional Drinker
1.867580E-01
Non Drinker-vs-Social Drinker
5.395800E-01
Daily Drinker-vs-Weekly Drinker
4.452600E-01
Daily Drinker-vs-Occasional Drinker
6.572600E-01
Daily Drinker-vs-Social Drinker
2.875000E-01
Weekly Drinker-vs-Occasional Drinker
2.048200E-01
Weekly Drinker-vs-Social Drinker
9.925800E-01
Occasional Drinker-vs-Social Drinker
7.666100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.299040E-01
Normal-vs-Grade 2
5.195900E-02
Normal-vs-Grade 3
4.316400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.380000E-02
Grade 1-vs-Grade 3
4.132000E-02
Grade 1-vs-Grade 4
1.299040E-01
Grade 2-vs-Grade 3
9.640800E-01
Grade 2-vs-Grade 4
5.195900E-02
Grade 3-vs-Grade 4
4.316400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.716000E-01
Normal-vs-NonDiabetic
2.962800E-01
Diabetic-vs-NonDiabetic
7.973000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.316200E-01
Normal-vs-NoPancreatitis
3.291800E-01
Pancreatitis-vs-NoPancreatitis
7.068000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.622400E-01
Normal-vs-N1
2.753400E-01
N0-vs-N1
5.292200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.62030999999452E-05
Normal-vs-TP53-NonMutant
7.636100E-03
TP53-Mutant-vs-TP53-NonMutant
6.544000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
